Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-14-354976
Filing Date
2014-09-26
Accepted
2014-09-26 17:05:03
Documents
5
Group Members
SPECTRUM PHARMACEUTICALS CAYMAN, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D d795423dsc13d.htm SC 13D 82909
2 EX-10.1 d795423dex101.htm EX-10.1 154925
3 EX-10.2 d795423dex102.htm EX-10.2 157097
4 EX-24.1 d795423dex241.htm EX-24.1 13610
5 EX-99.1 d795423dex991.htm EX-99.1 8226
  Complete submission text file 0001193125-14-354976.txt   418703
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filed by) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-46247 | Film No.: 141124616
SIC: 2836 Biological Products, (No Diagnostic Substances)